Related Experiment Video
Updated: Aug 7, 2025
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.1K
Control and Prevention of Invasive Pneumococcal Disease: A Current and Historical Perspective.
Pediatric Annals
|March 7, 2023
Summary
Invasive pneumococcal disease (IPD) in children has decreased due to vaccines, but serotype replacement remains a concern. New vaccines offer broader coverage, but awareness of evolving IPD strategies is crucial for pediatricians.
Area of Science:
- Pediatrics
- Vaccinology
- Infectious Diseases
Background:
- Invasive pneumococcal disease (IPD) incidence in children has decreased with pneumococcal conjugate vaccines (PCVs).
- Serotype replacement, where non-vaccine serotypes increase after PCV introduction, has partially reversed gains from PCV7 and PCV13.
- Antibiotic resistance in emerging replacement serotypes poses a significant challenge.
Purpose of the Study:
- To review the current landscape of IPD prevention in children.
- To highlight the challenges posed by serotype replacement and antibiotic resistance.
- To inform pediatricians about evolving vaccine strategies and IPD management.
Main Methods:
- Review of literature on IPD epidemiology and vaccine impact.
- Analysis of trends in serotype distribution and antibiotic resistance.
- Discussion of current and upcoming PCV formulations (PCV15, PCV20) and polysaccharide vaccine recommendations.
Main Results:
- PCVs have significantly reduced IPD rates, but serotype replacement remains an issue.
- Emerging serotypes are often antibiotic-resistant, complicating treatment.
- Higher-valency vaccines (PCV15, PCV20) aim for broader coverage but may not cover all new serotypes.
Conclusions:
- Pediatricians need to stay informed about new vaccine strategies for IPD prevention.
- Awareness of IPD manifestations is essential for timely empirical therapy.
- Evolving vaccine recommendations for high-risk populations require careful consideration.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
2.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
01:22Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
01:30Pneumonia III: Complications and Assessment
324
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
324
01:30Pneumonia I: Introduction
297
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
297
01:28Pneumonia IV: Management
410
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
410
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K